Change in Senior Management Personnel (SMP) of the Company

GRANULES Date: August 13, 2026 National Stock Exchange of India Limited & BSE Limited. Scrip Code: NSE- GRANULES; BSE-532482. Sub: Intimation of change of the Senior Management Personnel (“SMP”) Ref: Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “Listing Regulations”) Dear Sir/Mam, Pursuant to Regulation 30 of the Listing Regulations, we wish to inform you that the management of the Company has decided to internally transfer the services of Mr. Sanjay Kumar, Chief Strategy Officer and Senior Management Personnel (“SMP”) of the Company, to its wholly owned subsidiary, Ascelis Peptides Private Limited, with effect from August 13, 2026. Mr. Sanjay Kumar will assume the role of Chief Executive Officer (CEO) of Ascelis Peptides Private Limited. This transition reflects the Company’s view that a business of such scale, ambition, and complexity requires dedicated leadership with clear accountability. The details required under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, with respect to the above, is given in the Annexure enclosed herewith. Request you to take the above information on record. Thanking You. For GRANULES INDIA LIMITED CHAITANYA TUMMALA (COMPANY SECRETARY & COMPLIANCE OFFICER) Encl. as above. REGISTERED OFFICE Granules India Limited CIN: L24110TG1991PLCO12471 15" Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad - 500084, Telangana, India Contact Us: Tel: +91 40 69043500 | Fax: +91-40-23115145 | mail@granulesindia.com www.granulesindia.com GRANULES Annexure: Details under Regulation 30 of the SEBI Listing Regulations, read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. S.no. | Particulars Remarks 1. Name of the Senior Management | Mr. Sanjay Kumar Personnel 2. Reason for Change viz. Resignation due to internal transfer to the appetmentre-appotntiment wholly owned subsidiary of the Company + gRat'o n; a1kl : death otherwise 3. Date of appeintment/ire- | Effective from August 13, 2026 . . licabl appotniment: 4. Brief profile (in case of appointment); | Not Applicable 5. Disclosure of relationships between | Not Applicable Directors (in case of appointment of a director REGISTERED OFFICE Granules India Limited CIN: L24110TG1991PLCO012471 15® Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad - 500084, Telangana, India Contact Us: Tel: +9140 69043500 | Fax: +91-40-23115145 | mail@granulesindia.com www.granulesindia.com Wednesday, August 12, 2026 Dr. Krishna Prasad Chigurupati, Chairman & Managing Director, Granules India Limited, 15th Floor, Granules Tower, Botanical Garden Road, Kondapur, Hyderabad — 500084, Telangana, India Sub: Resignation from the position of Chief Strategy Officer of Granules India Limited (“Company”) Dear Sir, With reference to the captioned subject, I hereby tender my resignation from the position of Chief Strategy Officer of the Company, effective from August 13, 2026. This resignation is pursuant to my internal transfer as Chief Executive Officer of Ascelis Peptides Private Limited, a wholly owned subsidiary of the Company, as decided by the management. I sincerely appreciate the support and guidance extended to me by the Board of Directors, the Chairman & Managing Director and Leadership team of the Company during my tenure as Chief Strategy Officer. With regards :’”fié‘”l\/\gflww njay Kumar Chief Strategy Officer